annual D&A:
$236.19M+$6.79M(+2.96%)Summary
- As of today (May 29, 2025), AMRX annual depreciation & amortization is $236.19 million, with the most recent change of +$6.79 million (+2.96%) on December 31, 2024.
- During the last 3 years, AMRX annual D&A has risen by +$2.79 million (+1.19%).
- AMRX annual D&A is now -1.66% below its all-time high of $240.18 million, reached on December 31, 2022.
Performance
AMRX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$60.16M-$5.97M(-9.03%)Summary
- As of today (May 29, 2025), AMRX quarterly depreciation & amortization is $60.16 million, with the most recent change of -$5.97 million (-9.03%) on March 31, 2025.
- Over the past year, AMRX quarterly D&A has increased by +$4.63 million (+8.34%).
- AMRX quarterly D&A is now -9.03% below its all-time high of $66.13 million, reached on December 31, 2024.
Performance
AMRX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$240.82M+$4.63M(+1.96%)Summary
- As of today (May 29, 2025), AMRX TTM depreciation & amortization is $240.82 million, with the most recent change of +$4.63 million (+1.96%) on March 31, 2025.
- Over the past year, AMRX TTM D&A has increased by +$14.04 million (+6.19%).
- AMRX TTM D&A is now at all-time high.
Performance
AMRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AMRX Depreciation and amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +3.0% | +8.3% | +6.2% |
3 y3 years | +1.2% | +4.0% | +2.2% |
5 y5 years | +14.0% | +3.6% | +11.3% |
AMRX Depreciation and amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -1.7% | +3.0% | -9.0% | +8.3% | at high | +6.9% |
5 y | 5-year | -1.7% | +14.0% | -9.0% | +8.3% | at high | +11.3% |
alltime | all time | -1.7% | +615.4% | -9.0% | +307.8% | at high | +1532.6% |
AMRX Depreciation and amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $60.16M(-9.0%) | $240.82M(+2.0%) |
Dec 2024 | $236.19M(+3.0%) | $66.13M(+12.2%) | $236.19M(+4.1%) |
Sep 2024 | - | $58.96M(+6.1%) | $226.99M(+0.8%) |
Jun 2024 | - | $55.57M(+0.1%) | $225.24M(-0.7%) |
Mar 2024 | - | $55.53M(-2.5%) | $226.78M(-1.1%) |
Dec 2023 | $229.40M(-4.5%) | $56.93M(-0.5%) | $229.40M(-1.8%) |
Sep 2023 | - | $57.21M(+0.2%) | $233.52M(-1.9%) |
Jun 2023 | - | $57.11M(-1.8%) | $237.93M(-1.1%) |
Mar 2023 | - | $58.15M(-4.8%) | $240.51M(+0.1%) |
Dec 2022 | $240.18M(+2.9%) | $61.06M(-0.9%) | $240.18M(-0.1%) |
Sep 2022 | - | $61.61M(+3.2%) | $240.30M(+0.6%) |
Jun 2022 | - | $59.70M(+3.3%) | $238.88M(+1.4%) |
Mar 2022 | - | $57.81M(-5.5%) | $235.67M(+1.0%) |
Dec 2021 | $233.41M | $61.18M(+1.7%) | $233.41M(+0.6%) |
Sep 2021 | - | $60.19M(+6.5%) | $232.10M(+0.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2021 | - | $56.49M(+1.7%) | $231.27M(-0.7%) |
Mar 2021 | - | $55.55M(-7.2%) | $232.85M(-1.1%) |
Dec 2020 | $235.39M(+13.6%) | $59.87M(+0.9%) | $235.39M(+2.4%) |
Sep 2020 | - | $59.36M(+2.2%) | $229.82M(+2.7%) |
Jun 2020 | - | $58.07M(-0.0%) | $223.82M(+3.4%) |
Mar 2020 | - | $58.08M(+7.0%) | $216.45M(+4.4%) |
Dec 2019 | $207.24M(+50.8%) | $54.30M(+1.8%) | $207.24M(+3.4%) |
Sep 2019 | - | $53.36M(+5.2%) | $200.43M(+5.4%) |
Jun 2019 | - | $50.71M(+3.8%) | $190.08M(+10.8%) |
Mar 2019 | - | $48.87M(+2.9%) | $171.52M(+24.8%) |
Dec 2018 | $137.40M(+199.1%) | $47.49M(+10.4%) | $137.40M(+52.8%) |
Sep 2018 | - | $43.01M(+33.8%) | $89.91M(+91.7%) |
Jun 2018 | - | $32.15M(+117.9%) | $46.90M(+217.9%) |
Mar 2018 | - | $14.75M | $14.75M |
Dec 2017 | $45.94M(+39.1%) | - | - |
Dec 2016 | $33.02M | - | - |
FAQ
- What is Amneal Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual D&A year-on-year change?
- What is Amneal Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly D&A year-on-year change?
- What is Amneal Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals TTM D&A year-on-year change?
What is Amneal Pharmaceuticals annual depreciation & amortization?
The current annual D&A of AMRX is $236.19M
What is the all time high annual D&A for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual depreciation & amortization is $240.18M
What is Amneal Pharmaceuticals annual D&A year-on-year change?
Over the past year, AMRX annual depreciation & amortization has changed by +$6.79M (+2.96%)
What is Amneal Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of AMRX is $60.16M
What is the all time high quarterly D&A for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly depreciation & amortization is $66.13M
What is Amneal Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, AMRX quarterly depreciation & amortization has changed by +$4.63M (+8.34%)
What is Amneal Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of AMRX is $240.82M
What is the all time high TTM D&A for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high TTM depreciation & amortization is $240.82M
What is Amneal Pharmaceuticals TTM D&A year-on-year change?
Over the past year, AMRX TTM depreciation & amortization has changed by +$14.04M (+6.19%)